MS Neurology Sales Specialist: Infusion & Biosimilars

Syneos Health; Midlothian (IL); On-site; USD 165,000 - 185,000; Full time

Benefits offered by this job

Car allowance

Commission/bonus eligibility

Job summary

Syneos Health is seeking a Neurology Sales Specialist to drive market share in a defined U.S. territory.

You will deliver clinical, evidence-based messaging to physicians, HCPs, infusion clinics, and related staff, while building strategic partnerships and expanding access to therapies. The role requires 5+ years of pharmaceutical sales experience, with MS specialization and biosimilars/infusion therapy exposure.

Qualifications

• Excellent communication and interpersonal skills with a consultative selling approach.
• Ability to analyze sales analytics, prescribing trends and competitive dynamics.
• Proven track record of quota attainment and top-tier performance in pharmaceutical sales.
• Experience calling on neurologists and neurology center personnel within the territory.
• Understanding of biosimilars, infusion therapy, and buy-and-bill dynamics.

Responsibilities

• Execute strategic territory plan and deliver compliant, clinically compelling messaging.
• Identify and develop relationships with targeted healthcare providers and clinics.
• Navigate distribution channels and collaborate with practice managers and staff.
• Maintain CRM records, call reports, and sample tracking in line with policy.
• Analyze territory data to drive quarterly and annual sales goals.

Skills

Communication

Consultative selling

Business analytics

Strategic account management

Territory planning

Education

Bachelor's degree

Tools

CRM software

Job description

Syneos Health is seeking a Neurology Sales Specialist to drive market share in a defined U.S. territory.

You will deliver clinical, evidence-based messaging to physicians, HCPs, infusion clinics, and related staff, while building strategic partnerships and expanding access to therapies. The role requires 5+ years of pharmaceutical sales experience, with MS specialization and biosimilars/infusion therapy exposure.